AI assistant
Traws Pharma, Inc. — Director's Dealing 2013
Jul 29, 2013
35199_dirs_2013-07-29_62a08698-a7fa-45a4-8e0a-519e005a3e93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-25
Reporting Person: GROOPMAN JEROME (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-07-25 | Stock Option (right to purchase) | $15 | A | 20000 | Acquired | 2023-07-25 | Common Stock (20000) | Direct |
| 2013-07-25 | Stock Option (right to purchase) | $15 | A | 10000 | Acquired | 2023-07-25 | Common Stock (10000) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 20,000 shares of Common Stock, is immediately exercisable and vests in three equal installments on July 25, 2014, 2015 and 2016, subject to continued service to the Issuer through each vesting date.
F2: This option, representing a right to purchase a total of 10,000 shares of Common Stock, is immediately exercisable and vests over 12 months from July 25, 2013, with 1/12th vesting on August 25, 2013 and 11/12th vesting in 11 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.